PMC:7102662 / 5255-5784 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T52","span":{"begin":100,"end":108},"obj":"Disease"},{"id":"T53","span":{"begin":409,"end":417},"obj":"Disease"},{"id":"T54","span":{"begin":480,"end":484},"obj":"Disease"}],"attributes":[{"id":"A52","pred":"mondo_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A53","pred":"mondo_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A54","pred":"mondo_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"This review is aimed at providing overview of various CV manifestations in patients presenting with COVID-19. The impact of pre-existing CVD and new onset cardiac complications on clinical outcomes in these patients is also discussed. Since our understanding on this subject is only evolving at this stage, the information contained in the subsequent text is based mainly on the limited early experience with COVID-19 and learnings from the previous coronavirus illnesses, namely SARS and Middle-East Respiratory Syndrome (MERS)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T9","span":{"begin":422,"end":431},"obj":"http://purl.obolibrary.org/obo/GO_0007612"}],"text":"This review is aimed at providing overview of various CV manifestations in patients presenting with COVID-19. The impact of pre-existing CVD and new onset cardiac complications on clinical outcomes in these patients is also discussed. Since our understanding on this subject is only evolving at this stage, the information contained in the subsequent text is based mainly on the limited early experience with COVID-19 and learnings from the previous coronavirus illnesses, namely SARS and Middle-East Respiratory Syndrome (MERS)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T49","span":{"begin":0,"end":109},"obj":"Sentence"},{"id":"T50","span":{"begin":110,"end":234},"obj":"Sentence"},{"id":"T51","span":{"begin":235,"end":529},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This review is aimed at providing overview of various CV manifestations in patients presenting with COVID-19. The impact of pre-existing CVD and new onset cardiac complications on clinical outcomes in these patients is also discussed. Since our understanding on this subject is only evolving at this stage, the information contained in the subsequent text is based mainly on the limited early experience with COVID-19 and learnings from the previous coronavirus illnesses, namely SARS and Middle-East Respiratory Syndrome (MERS)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T95","span":{"begin":100,"end":108},"obj":"SP_7"},{"id":"T96","span":{"begin":155,"end":162},"obj":"UBERON:0000948"},{"id":"T97","span":{"begin":409,"end":417},"obj":"SP_7"},{"id":"T98","span":{"begin":422,"end":431},"obj":"GO:0007612"},{"id":"T99","span":{"begin":450,"end":461},"obj":"NCBITaxon:11118"},{"id":"T100","span":{"begin":480,"end":484},"obj":"SP_10"},{"id":"T101","span":{"begin":523,"end":527},"obj":"SP_9"}],"text":"This review is aimed at providing overview of various CV manifestations in patients presenting with COVID-19. The impact of pre-existing CVD and new onset cardiac complications on clinical outcomes in these patients is also discussed. Since our understanding on this subject is only evolving at this stage, the information contained in the subsequent text is based mainly on the limited early experience with COVID-19 and learnings from the previous coronavirus illnesses, namely SARS and Middle-East Respiratory Syndrome (MERS)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"159","span":{"begin":75,"end":83},"obj":"Species"},{"id":"160","span":{"begin":207,"end":215},"obj":"Species"},{"id":"161","span":{"begin":450,"end":461},"obj":"Species"},{"id":"162","span":{"begin":100,"end":108},"obj":"Disease"},{"id":"163","span":{"begin":137,"end":140},"obj":"Disease"},{"id":"164","span":{"begin":155,"end":176},"obj":"Disease"},{"id":"165","span":{"begin":409,"end":417},"obj":"Disease"},{"id":"166","span":{"begin":489,"end":521},"obj":"Disease"},{"id":"167","span":{"begin":523,"end":527},"obj":"Disease"}],"attributes":[{"id":"A159","pred":"tao:has_database_id","subj":"159","obj":"Tax:9606"},{"id":"A160","pred":"tao:has_database_id","subj":"160","obj":"Tax:9606"},{"id":"A161","pred":"tao:has_database_id","subj":"161","obj":"Tax:11118"},{"id":"A162","pred":"tao:has_database_id","subj":"162","obj":"MESH:C000657245"},{"id":"A163","pred":"tao:has_database_id","subj":"163","obj":"MESH:D002318"},{"id":"A164","pred":"tao:has_database_id","subj":"164","obj":"MESH:D005117"},{"id":"A165","pred":"tao:has_database_id","subj":"165","obj":"MESH:C000657245"},{"id":"A166","pred":"tao:has_database_id","subj":"166","obj":"MESH:D018352"},{"id":"A167","pred":"tao:has_database_id","subj":"167","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"This review is aimed at providing overview of various CV manifestations in patients presenting with COVID-19. The impact of pre-existing CVD and new onset cardiac complications on clinical outcomes in these patients is also discussed. Since our understanding on this subject is only evolving at this stage, the information contained in the subsequent text is based mainly on the limited early experience with COVID-19 and learnings from the previous coronavirus illnesses, namely SARS and Middle-East Respiratory Syndrome (MERS)."}